Blocking CXCR4+ CD4+ T cells reprograms Treg-mediated immunosuppression via modulating the Rho-GTPase/NF-κB signaling axis

Abstract Background While clinical trials have shown that CXCR4 antagonists can enhance the efficacy of cancer immunotherapy, the molecular mechanisms by which CXCR4 modulates the tumor microenvironment remain poorly understood. We recently identified CXCR4 as a regulator of exhausted CD8+ T cell ph...

Full description

Saved in:
Bibliographic Details
Main Authors: Canhui Cao, Miaochun Xu, Ting Peng, Xiaojie Liu, Shitong Lin, Yashi Xu, Tian Chu, Shiyi Liu, Ping Wu, Bai Hu, Wencheng Ding, Li Li, Ding Ma, Peng Wu
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Genome Medicine
Subjects:
Online Access:https://doi.org/10.1186/s13073-025-01515-8
Tags: Add Tag
No Tags, Be the first to tag this record!